Tilray Brands (TLRY) Non-Current Debt (2020 - 2026)
Tilray Brands (TLRY) reported Non-Current Debt of $135.0 million for Q1 2026, down 2.71% quarter-over-quarter from $138.7 million in Q4 2025.
Tilray Brands (TLRY) Non-Current Debt (2020 - 2026) Analysis & Trends
Tilray Brands has reported Non-Current Debt for 7 years, with the latest figure at $135.0 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Debt changed N/A year-over-year to $135.0 million; the trailing twelve-month figure through Feb 2026 stood at $135.0 million (changed N/A YoY), and the FY2025 full-year result was $148.5 million, down 6.23% from the prior year.
- Non-Current Debt for Q1 2026 stood at $135.0 million, down from $138.7 million in the prior quarter.
- The five-year high for Non-Current Debt was $169.1 million in Q4 2023, with the low at $89.4 million in Q1 2023.
- Historically, Non-Current Debt has averaged $140.5 million across 5 years, with a median of $146.3 million in 2025.
- Annual changes were most pronounced in 2022 — Non-Current Debt sank 30.69% — and 2024, when it surged 85.25%.
- Tilray Brands' Non-Current Debt stood at $152.2 million in 2022, then climbed by 11.14% to $169.1 million in 2023, then retreated by 11.96% to $148.9 million in 2024, then dropped by 6.81% to $138.7 million in 2025, then slipped by 2.71% to $135.0 million in 2026.
- The last three Non-Current Debt figures came in at $135.0 million (Q1 2026), $138.7 million (Q4 2025), and $144.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 569.60 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Tilray Brands | - | - | 54.95 Mn | 134.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 134.98 Mn |
| Feb 28, 2026 | 134.98 Mn |
| Nov 30, 2025 | 138.74 Mn |
| Nov 30, 2025 | 138.74 Mn |
| Aug 31, 2025 | 144.18 Mn |
| Aug 31, 2025 | 144.18 Mn |
| May 31, 2025 | 148.49 Mn |
| May 31, 2025 | 148.49 Mn |
| Nov 30, 2024 | 148.87 Mn |
| Nov 30, 2024 | 148.87 Mn |
| Aug 31, 2024 | 155.27 Mn |
| Aug 31, 2024 | 155.27 Mn |
| May 31, 2024 | 158.35 Mn |
| May 31, 2024 | 158.35 Mn |
| Feb 29, 2024 | 165.65 Mn |
| Feb 29, 2024 | 165.65 Mn |
| Nov 30, 2023 | 169.10 Mn |
| Nov 30, 2023 | 169.10 Mn |
| Aug 31, 2023 | 152.39 Mn |
| Aug 31, 2023 | 152.39 Mn |